TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 DKK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
623
|
509
|
712 |
| Financial expenses |
38
|
0
|
4 |
| Earnings before taxes |
132
|
195
|
433 |
| EBITDA |
169
|
189
|
436 |
| Total assets |
941
|
906
|
861 |
| Current assets |
904
|
881
|
858 |
| Current liabilities |
589
|
322
|
393 |
| Equity capital |
342
|
575
|
458 |
| - share capital |
33
|
33
|
35 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
36.3%
|
63.5%
|
53.2% |
| Turnover per employee |
623
|
509
|
712 |
| Profit as a percentage of turnover |
21.2%
|
38.3%
|
60.8% |
| Return on assets (ROA) |
18.1%
|
21.5%
|
50.8% |
| Current ratio |
153.5%
|
273.6%
|
218.3% |
| Return on equity (ROE) |
38.6%
|
33.9%
|
94.5% |
| Change turnover |
113
|
-153
|
187 |
| Change turnover % |
22%
|
-23%
|
36% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.